MarketBeat Instant News Alerts 2 hours agoEmpire Metals (LON:EEE) Trading 8.1% Higher - Here's WhyMarketBeatEmpire Metals (LON:EEE) Shares Up 8.1% - Here's WhyLON:EEERead Empire Metals (LON:EEE) Trading 8.1% Higher - Here's Why2 hours agoIP Group (LON:IPO) Stock Price Up 11.6% - Here's What HappenedMarketBeatIP Group (LON:IPO) Shares Up 11.6% - Time to Buy?LON:IPORead IP Group (LON:IPO) Stock Price Up 11.6% - Here's What Happened2 hours agohVIVO (LON:HVO) Shares Up 12.3% - Time to Buy?MarketBeathVIVO (LON:HVO) Shares Up 12.3% - Should You Buy?LON:HVORead hVIVO (LON:HVO) Shares Up 12.3% - Time to Buy?2 hours agoBig Yellow Group (LON:BYG) Trading 14.8% Higher - What's Next?MarketBeatBig Yellow Group (LON:BYG) Stock Price Up 14.8% - Here's WhyLON:BYGRead Big Yellow Group (LON:BYG) Trading 14.8% Higher - What's Next?2 hours agoNetskope Inc. (NASDAQ:NTSK) Receives Consensus Recommendation of "Buy" from BrokeragesMarketBeatNetskope Inc. (NASDAQ:NTSK - Get Free Report) has been assigned an average rating of "Buy" from the eleven analysts that are presently covering the company, Marketbeat.com reports. Eleven investment analysts have rated the stock with a buy recommendation. The average twelve-month price target amonNASDAQ:NTSKRead Netskope Inc. (NASDAQ:NTSK) Receives Consensus Recommendation of "Buy" from Brokerages2 hours agoCorvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Given Average Recommendation of "Moderate Buy" by AnalystsMarketBeatShares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five brokerages that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating and four have given aNASDAQ:CRVSRead Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Given Average Recommendation of "Moderate Buy" by Analysts Trending News1D-Wave Quantum (NYSE:QBTS) Downgraded to "Strong Sell" Rating by Zacks Research242,830 Shares in Archer Aviation Inc. $ACHR Purchased by Clear Creek Financial Management LLC3IonQ (NYSE:IONQ) Shares Down 4.3% - Here's What Happened4NVIDIA (NASDAQ:NVDA) CEO Sells $14,129,250.00 in Stock5Plug Power (NASDAQ:PLUG) Stock Rating Upgraded by Hsbc Global Res6Intel (NASDAQ:INTC) Stock Price Expected to Rise, TD Cowen Analyst Says7Canadian Natural Resources (TSE:CNQ) Stock Price Passes Above 200 Day Moving Average After Insider Selling8Kratos Defense & Security Solutions (NASDAQ:KTOS) Stock Price Down 6.6% After Analyst Downgrade All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoGlaukos (NYSE:GKOS) Price Target Lowered to $104.00 at BTIG ResearchMarketBeatNYSE:GKOSRead Glaukos (NYSE:GKOS) Price Target Lowered to $104.00 at BTIG Research2 hours agoThe Goldman Sachs Group Upgrades Estee Lauder Companies (NYSE:EL) to "Buy"MarketBeatNYSE:ELRead The Goldman Sachs Group Upgrades Estee Lauder Companies (NYSE:EL) to "Buy"2 hours agoZimmer Biomet (NYSE:ZBH) Given New $122.00 Price Target at BTIG ResearchMarketBeatNYSE:ZBHRead Zimmer Biomet (NYSE:ZBH) Given New $122.00 Price Target at BTIG Research2 hours agoCelldex Therapeutics (NASDAQ:CLDX) Now Covered by Analysts at BarclaysMarketBeatNASDAQ:CLDXRead Celldex Therapeutics (NASDAQ:CLDX) Now Covered by Analysts at Barclays2 hours agoNioCorp Developments (NASDAQ:NB) Releases Q1 2026 Earnings GuidanceMarketBeatNASDAQ:NBRead NioCorp Developments (NASDAQ:NB) Releases Q1 2026 Earnings Guidance2 hours agoAbeona Therapeutics' (ABEO) "Buy" Rating Reiterated at HC WainwrightMarketBeatNASDAQ:ABEORead Abeona Therapeutics' (ABEO) "Buy" Rating Reiterated at HC Wainwright2 hours agoAdvanced Energy Industries (NASDAQ:AEIS) Price Target Raised to $188.00MarketBeatNASDAQ:AEISRead Advanced Energy Industries (NASDAQ:AEIS) Price Target Raised to $188.002 hours agoBaldwin Insurance Group's (BWIN) Market Perform Rating Reaffirmed at BMO Capital MarketsMarketBeatNASDAQ:BWINRead Baldwin Insurance Group's (BWIN) Market Perform Rating Reaffirmed at BMO Capital Markets2 hours agoRobert W. Baird Issues Positive Forecast for eBay (NASDAQ:EBAY) Stock PriceMarketBeatNASDAQ:EBAYRead Robert W. Baird Issues Positive Forecast for eBay (NASDAQ:EBAY) Stock Price2 hours agoeToro Group (NASDAQ:ETOR) Coverage Initiated at Compass PointMarketBeatNASDAQ:ETORRead eToro Group (NASDAQ:ETOR) Coverage Initiated at Compass Point2 hours agoGain Therapeutics (NASDAQ:GANX) Given "Buy" Rating at HC WainwrightMarketBeatNASDAQ:GANXRead Gain Therapeutics (NASDAQ:GANX) Given "Buy" Rating at HC Wainwright2 hours agoHumacyte (NASDAQ:HUMA) Price Target Cut to $6.00 by Analysts at BTIG ResearchMarketBeatNASDAQ:HUMARead Humacyte (NASDAQ:HUMA) Price Target Cut to $6.00 by Analysts at BTIG Research2 hours agoIntuitive Surgical (NASDAQ:ISRG) Given New $529.00 Price Target at BTIG ResearchMarketBeatNASDAQ:ISRGRead Intuitive Surgical (NASDAQ:ISRG) Given New $529.00 Price Target at BTIG Research2 hours agoNeedham & Company LLC Increases MKS (NASDAQ:MKSI) Price Target to $136.00MarketBeatNASDAQ:MKSIRead Needham & Company LLC Increases MKS (NASDAQ:MKSI) Price Target to $136.002 hours agoMannKind (NASDAQ:MNKD) Given "Buy" Rating at HC WainwrightMarketBeatNASDAQ:MNKDRead MannKind (NASDAQ:MNKD) Given "Buy" Rating at HC Wainwright2 hours agoBTIG Research Initiates Coverage on Netskope (NASDAQ:NTSK)MarketBeatNASDAQ:NTSKRead BTIG Research Initiates Coverage on Netskope (NASDAQ:NTSK)2 hours agoNetskope (NASDAQ:NTSK) Now Covered by JPMorgan Chase & Co.MarketBeatNASDAQ:NTSKRead Netskope (NASDAQ:NTSK) Now Covered by JPMorgan Chase & Co.2 hours agoTransMedics Group (NASDAQ:TMDX) Earns Buy Rating from Analysts at Jefferies Financial GroupMarketBeatNASDAQ:TMDXRead TransMedics Group (NASDAQ:TMDX) Earns Buy Rating from Analysts at Jefferies Financial Group2 hours agoArgan (NYSE:AGX) Upgraded to Overweight at JPMorgan Chase & Co.MarketBeatNYSE:AGXRead Argan (NYSE:AGX) Upgraded to Overweight at JPMorgan Chase & Co.2 hours agoCarlisle Companies (NYSE:CSL) Price Target Cut to $385.00 by Analysts at Robert W. BairdMarketBeatNYSE:CSLRead Carlisle Companies (NYSE:CSL) Price Target Cut to $385.00 by Analysts at Robert W. Baird2 hours agoJanney Montgomery Scott Reaffirms Neutral Rating for Eversource Energy (NYSE:ES)MarketBeatNYSE:ESRead Janney Montgomery Scott Reaffirms Neutral Rating for Eversource Energy (NYSE:ES)2 hours agoFastenal (NASDAQ:FAST) Posts Earnings Results, Misses Expectations By $0.01 EPSMarketBeatNASDAQ:FASTRead Fastenal (NASDAQ:FAST) Posts Earnings Results, Misses Expectations By $0.01 EPS3 hours agoIP Group (LON:IPO) Trading 11.4% Higher - Here's WhyMarketBeatLON:IPORead IP Group (LON:IPO) Trading 11.4% Higher - Here's Why3 hours agohVIVO (LON:HVO) Trading 13% Higher - Should You Buy?MarketBeatLON:HVORead hVIVO (LON:HVO) Trading 13% Higher - Should You Buy? Featured Articles and OffersD-Wave Quantum (NYSE:QBTS) Downgraded to "Strong Sell" Rating by Zacks ResearchBy MarketBeat | October 8, 2025Bitcoin grabs headlines, but smart money likes this tokenFrom Crypto 101 Media (Ad)Quantum Computing Stocks To Keep An Eye On - October 7thBy MarketBeat | October 10, 2025When Downgrades Create Opportunities: 3 Stocks to Watch NowBy Thomas Hughes | October 7, 2025EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming SectorBy Nathan Reiff | October 7, 20252013 Bitcoin miner reveals his trading system (free)From Crypto Swap Profits (Ad)Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer DealBy Leo Miller | October 6, 2025Why Amazon’s Prime Day May Be the Catalyst for a Year-End RallyBy Sam Quirke | October 9, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
